188 related articles for article (PubMed ID: 25827817)
41. Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial.
Lepage C; Phelip JM; Cany L; Faroux R; Manfredi S; Ain JF; Pezet D; Baconnier M; Deguiral P; Terrebone E; Adenis A; Le Malicot K; Bedenne L; Bouché O
Dig Liver Dis; 2015 Jul; 47(7):529-31. PubMed ID: 25933809
[No Abstract] [Full Text] [Related]
42. Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study.
Bhattacharjya S; Aggarwal R; Davidson BR
Br J Cancer; 2006 Jul; 95(1):21-6. PubMed ID: 16804525
[TBL] [Abstract][Full Text] [Related]
43. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
44. Microwave ablation with or without resection for colorectal liver metastases.
Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
[TBL] [Abstract][Full Text] [Related]
45. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
46. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
[TBL] [Abstract][Full Text] [Related]
47. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level.
Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh B; Kapoor R; Gupta R
Nucl Med Commun; 2011 Sep; 32(9):789-93. PubMed ID: 21760561
[TBL] [Abstract][Full Text] [Related]
48. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
49. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
50. Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?
Mortazavi A; Shaukat A; Othman E; Kepner JL; Fakih MG; Kuvshinoff BW; Smith JL; Javle MM
Am J Clin Oncol; 2005 Feb; 28(1):30-5. PubMed ID: 15685032
[TBL] [Abstract][Full Text] [Related]
51. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study.
Cummings KC; Xu F; Cummings LC; Cooper GS
Anesthesiology; 2012 Apr; 116(4):797-806. PubMed ID: 22273991
[TBL] [Abstract][Full Text] [Related]
52. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
53. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
54. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
55. Postherapeutic follow-up of colorectal cancer patients treated with curative intent.
Mazilu L; Ciufu N; Gălan M; Suceveanu AI; Suceveanu AP; Parepa IR; Tofolean D
Chirurgia (Bucur); 2012; 107(1):55-8. PubMed ID: 22480117
[TBL] [Abstract][Full Text] [Related]
56. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial.
Mäkelä JT; Laitinen SO; Kairaluoma MI
Arch Surg; 1995 Oct; 130(10):1062-7. PubMed ID: 7575117
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
58. [Influence of structured CEA determination and CT-scan to detect recurrence of colorectal cancer: results of the randomized clinical FACS study].
Reibetanz J; Germer CT
Chirurg; 2014 Jul; 85(7):642. PubMed ID: 25000931
[No Abstract] [Full Text] [Related]
59. Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study.
Backes Y; de Vos Tot Nederveen Cappel WH; van Bergeijk J; Ter Borg F; Schwartz MP; Spanier BWM; Geesing JMJ; Kessels K; Kerkhof M; Groen JN; Wolfhagen FHJ; Seerden TCJ; van Lelyveld N; Offerhaus GJA; Siersema PD; Lacle MM; Moons LMG
Am J Gastroenterol; 2017 May; 112(5):785-796. PubMed ID: 28323275
[TBL] [Abstract][Full Text] [Related]
60. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
